NASDAQ:ITOS
iTeos Therapeutics, Inc.
- Stock
Last Close
16.71
26/07 20:00
Market Cap
550.87M
Beta: 1.33
Volume Today
169.95K
Avg: 246.75K
PE Ratio
−5.98
PFCF: −3.10
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -18.06M - | -22.45M 24.35% | -38.03M 69.38% | 214.52M 664.04% | 96.65M 54.95% | -112.64M 216.54% | |
depreciation and amortization | 505K - | 611K 20.99% | 535K 12.44% | 603K 12.71% | 803K 33.17% | 898K 11.83% | |
deferred income tax | 130K - | -1.02M 883.85% | -1.26M 24.14% | -3.04M - | |||
stock based compensation | 112K - | 809K 622.32% | 4.29M 430.53% | 13.79M 221.39% | 21.56M 56.31% | 27.02M 25.32% | |
change in working capital | -1.86M - | -1.08M 41.70% | 9.33M 962.29% | 284.21M 2,946.20% | -228.49M 180.40% | -8.80M 96.15% | |
accounts receivables | 1.09M - | -4.85M 546.55% | 5.03M 203.69% | -3.34M 166.44% | 3.99M 219.26% | -2.38M 159.80% | |
inventory | -1.27M - | 4.85M 481.00% | -5.03M 203.69% | 3.34M 166.44% | -3.99M 219.26% | 2.38M 159.80% | |
accounts payables | -133K - | -155K 16.54% | 1.68M 1,181.94% | 2.28M 35.96% | 2.76M 21.10% | 3.04M 9.96% | |
other working capital | -1.54M - | -927K 39.65% | 7.65M 925.57% | 281.93M 3,583.91% | -231.25M 182.02% | -11.84M 94.88% | |
other non cash items | 69K - | -10K 114.49% | -35K 250% | 12K 134.29% | -1.72M 14,416.67% | -7.20M 318.98% | |
net cash provided by operating activities | -19.10M - | -23.14M 21.20% | -25.18M 8.78% | 513.14M 2,138.21% | -111.19M 121.67% | -103.76M 6.69% | |
investments in property plant and equipment | -226K - | -721K 219.03% | -356K 50.62% | -1.18M 231.74% | -938K 20.58% | -2.97M 216.20% | |
acquisitions net | |||||||
purchases of investments | -445.00M - | -290.54M 34.71% | |||||
sales maturities of investments | 366.26M - | ||||||
other investing activites | -73K - | -205K 180.82% | -21K 89.76% | -61K 190.48% | -120K 96.72% | -99K 17.50% | |
net cash used for investing activites | -299K - | -926K 209.70% | -377K 59.29% | -1.24M 229.44% | -446.06M 35,814.81% | 72.66M 116.29% | |
debt repayment | |||||||
common stock issued | 22.47M - | 213.66M 850.70% | 2.94M 98.62% | 925K 68.57% | 1.11M 20.32% | ||
common stock repurchased | -226K - | -332K - | |||||
dividends paid | |||||||
other financing activites | 23.73M - | 65K 99.73% | 127.01M 195,301.54% | 716K 99.44% | 1.06M 47.91% | ||
net cash used provided by financing activities | 23.51M - | 22.54M 4.12% | 340.34M 1,410.00% | 3.66M 98.92% | 1.98M 45.78% | 1.11M 43.90% | |
effect of forex changes on cash | -875K - | -532K 39.20% | 1.68M 415.41% | -3.18M 289.27% | -8.53M 168.45% | -3.60M 57.75% | |
net change in cash | 3.24M - | -2.06M 163.76% | 316.46M 15,432.56% | 512.38M 61.91% | -563.80M 210.03% | -33.59M 94.04% | |
cash at beginning of period | 18.82M - | 22.05M 17.20% | 19.99M 9.36% | 336.45M 1,583.11% | 848.84M 152.29% | 285.04M 66.42% | |
cash at end of period | 22.05M - | 19.99M 9.36% | 336.45M 1,583.11% | 848.84M 152.29% | 285.04M 66.42% | 251.45M 11.78% | |
operating cash flow | -19.10M - | -23.14M 21.20% | -25.18M 8.78% | 513.14M 2,138.21% | -111.19M 121.67% | -103.76M 6.69% | |
capital expenditure | -226K - | -721K 219.03% | -356K 50.62% | -1.18M 231.74% | -938K 20.58% | -2.97M 216.20% | |
free cash flow | -19.32M - | -23.87M 23.51% | -25.53M 6.98% | 511.96M 2,105.17% | -112.13M 121.90% | -106.72M 4.82% |
All numbers in USD (except ratios and percentages)